Details for Patent: 6,143,326

Summary for Patent: 6,143,326

Title:	Oral pharmaceutical preparation containing ibandronat
Abstract:	The invention is directed to well-tolerated pharmaceutical compositions for oral application, containing ibandronate or a physiologically tolerable salt thereof as active substance, the administration form consisting of an active substance-containing inner portion enclosed in such fashion by a coat free of active substance that rapid release of the active substance takes place.
Inventor(s):	Mockel; Jorn (Heidelberg, DE), Gabel; Rolf-Dieter (Schwetzingen, DE), Woog; Heinrich (Laudenbach, DE)
Assignee:	Roche Diagnostics GmbH (Mannheim, DE)
Application Number:	09/147,149
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 6,143,326

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

Foreign Priority and PCT Information for Patent: 6,143,326

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Germany	196 15 812	Apr 20, 1996

PCT Information
PCT Filed	April 21, 1997	PCT Application Number:	PCT/EP97/01940
PCT Publication Date:	October 30, 1997	PCT Publication Number:	WO97/39755

International Family Members for US Patent 6,143,326

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	006652
Argentina	054350
Austria	404207
Australia	2638297